Traditionally, drug discovery has focused on small molecules, but peptidic partners are rapidly receiving attention. This innovative approach utilizes combining short amino acid chains with complementary therapeutic methods to address challenging disease mechanisms. By utilizing the unique characteristics of peptidic compounds – such as significa